查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378596

治疗性蛋白质和口服疫苗市场：按药物类别、按应用、按配销通路、按地区

Therapeutic Proteins And Oral Vaccines Market, By Drug Class (Therapeutic Proteins, Oral Vaccines ), By Application, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球治疗性蛋白质和口服疫苗市场估计为2.467亿美元，预计在预测期内（2023-2030年）年复合成长率为8.1%。

报告范围 报告详情
基准年 2022年 2023年市场规模 2.467 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 8.10% 2030年市场规模预测 4.248 亿美元
图 1. 2023 年治疗性蛋白质和口服疫苗的全球市场占有率（按药物类别划分）
治疗性蛋白质与口服疫苗市场-IMG1

治疗性蛋白质是临床上使用生物製药的主要选择之一。蛋白质是具有大分子量的有机化合物。它对癌症、后天免疫力缺乏症候群（爱滋病）和各种感染疾病具有治疗作用。当蛋白质用于治疗目的时，它被称为治疗性蛋白质。治疗性蛋白质是在实验室中出于製药目的而操作的蛋白质，用于生产治疗糖尿病的胰岛素。治疗性蛋白质在体内非常有效，并彻底改变了疾病治疗。与任何其他疫苗接种途径相比，口服免疫被认为是最方便的疫苗接种途径，因为它比传统疫苗配备更好。透过口服疫苗获得黏膜免疫，可以作为人与人或动物与人之间病原体性行为感染的保护剂，也可以保护黏膜区域免受病原体的侵害，这是微生物进入人体血液循环的最优选途径。宿主。能抑制有性复製。

市场动态

治疗性蛋白质和口服疫苗市场的主要参与者专注于疫苗和产品开发以及市场参与者的研究和开发。因此，将此类先进产品引入市场预计将在预测期内推动全球治疗性蛋白质和口服疫苗市场的成长。例如，2022 年 9 月，临床阶段生物技术公司 Vaxart, Inc. 宣布计划分两部分进行其武汉 S专用锭剂COVID-19 候选疫苗VXA-CoV2-1.1-S 的II 期试验。报告了良好的顶线资料从审判的第一部分开始。这些资料表明该研究达到了主要安全性和次要免疫抗原性原性终点，并将支持基于 Omicron 的新疫苗结构的持续开发。

本次测试的主要特点

  • 该报告详细分析了全球治疗性蛋白质和口服疫苗市场，并提供了以 2022 年为基准年的预测期（2023-2030）的市场规模。
  • 它揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球治疗性蛋白质和口服疫苗市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 全球治疗性蛋白质和口服疫苗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球治疗性蛋白质和口服疫苗市场的各种策略矩阵来促进他们的决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 最近测试启动
  • 流行病学
  • 合併、收购和合作
  • 法规场景
  • 主要进展
  • PEST分析

第4章全球治疗性蛋白质与口服疫苗市场-新型冠状病毒感染疾病（COVID-19）的影响分析

  • 经济影响
  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 对需求和供给的影响

第5章全球治疗性蛋白质和口服疫苗市场，依药物类别，2018-2030

  • 治疗性蛋白质
  • 生长因子
  • 融合蛋白
  • 单株抗体
  • 荷尔蒙
  • 凝血因子
  • 其他的
  • 口服疫苗
  • 减毒活病毒疫苗
  • 灭活疫苗
  • 重组疫苗
  • 其他的

第6章2018-2030年全球治疗性蛋白质与口服疫苗市场（依应用）

  • 肿瘤学
  • 血液学
  • 免疫学
  • 内分泌学
  • 感染疾病
  • 循环系统疾病
  • 其他的

第7章全球治疗性蛋白质和口服疫苗市场，按配销通路，2018-2030 年

  • 医院药房
  • 零售药房
  • 网路药房

第8章2018-2030年全球治疗性蛋白质与口服疫苗市场（按地区）

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • 公司简介
    • Abbott Laboratories
    • Amgen, Inc.
    • Biogen, Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Johnson and Johnson
    • Merck &Co. Inc.
    • Novo Nordisk A/S
    • Pfizer, Inc.
    • Sanofi SA
    • Serum Institute of India Pvt. Ltd.
    • Emergent Biosolutions Inc.
    • TransAlgae
    • MigVax Ltd.
    • Lumen Bioscience, Inc.

第10章章

  • 参考
  • 调查方法
简介目录
Product Code: CMI4396

The Global Therapeutic Proteins And Oral Vaccines Market is estimated to be valued at US$ 246.7 Mn in 2023 and is expected to exhibit a CAGR of 8.1% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 246.7 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.10% 2030 Value Projection: US$ 424.8 Mn
Figure 1. Global Therapeutic Proteins and Oral Vaccines Market Share (%), By Drug Class, 2023
Therapeutic Proteins And Oral Vaccines Market - IMG1

Therapeutic proteins are one of the prime options for biologicals as per their clinical uses. Proteins are organic compounds with a higher molecular weight. This have therapeutic effects against various diseases like cancer, Acquired immunodeficiency syndrome (AIDS), and various infectious diseases. When protein is used for therapeutic purposes, it is known as a therapeutic protein. Therapeutic proteins are proteins that are engineered in the laboratory for pharmaceutical purposes in the making of insulin to treat diabetes. Therapeutic proteins are highly effective in vivo and have revolutionized the treatment of diseases. Oral immunization is considered the most convenient route of vaccination rather than any other route due to its abundance of facilities over the traditional vaccines. Gaining of mucosal immunity through oral vaccination can act as a protector against human-to-human or animal-to-human pathogenic transmission of diseases and also inhibit the pathogenic replication in the mucosal area which is the most preferable able route of microbe's penetration to the host blood circulation.

Market Dynamics

The key players in the therapeutic proteins and oral vaccines market are focusing on the development of vaccines, products, and research and development by market players. Thus, the introduction of such advanced products into the market is expected to drive growth of the global therapeutic proteins and oral vaccines market over the forecast period. For instance, in September 2022, Vaxart, Inc., a clinical-stage biotechnology company, reported positive top-line data from the first part of a planned two-part Phase II study of its Wuhan S-only oral pill COVID-19 vaccine candidate, VXA-CoV2-1.1-S. The data demonstrate that the trial met its primary safety and secondary immunogenicity endpoints and will inform the ongoing development of new Omicron-based vaccine constructs.

Key features of the study:

  • This report provides an in-depth analysis of the global therapeutic proteins and oral vaccines market and provides market size (US$ Mn and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global global therapeutic proteins and oral vaccines market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson and Johnson, Merck & Co.Inc., Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc., TransAlgae, MigVax Ltd., and Lumen Bioscience, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global therapeutic proteins and oral vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global therapeutic proteins and oral vaccines market

Therapeutic Proteins And Oral Vaccines Market Detailed Segmentation:

  • By Drug Class:
    • Therapeutic Proteins
    • Growth Factors
    • Fusion Proteins
    • Monoclonal Antibodies
    • Hormones
    • Coagulation Factors
    • Others
    • Oral Vaccines
    • Live Attenuated Vaccine
    • Inactivated Vaccine
    • Recombinant Vaccine
    • Others
  • By Application:
    • Oncology
    • Hematology
    • Immunology
    • Endocrinology
    • Infectious Disease
    • Cardiovascular Disease
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Abbott Laboratories
    • Amgen, Inc.
    • Biogen, Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Johnson and Johnson
    • Merck & Co.Inc.
    • Novo Nordisk A/S
    • Pfizer, Inc.
    • Sanofi S.A.
    • Serum Institute of India Pvt. Ltd.
    • Emergent Biosolutions Inc.
    • TransAlgae
    • MigVax Ltd.
    • Lumen Bioscience, Inc.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Therapeutic Proteins and Oral Vaccines Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Therapeutic Proteins and Oral Vaccines Market, By Drug Class, 2018- 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Therapeutic Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Growth Factors
  • Fusion Proteins
  • Monoclonal Antibodies
  • Hormones
  • Coagulation Factors
  • Others
  • Oral Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Recombinant Vaccine
  • Others

6. Global Therapeutic Proteins and Oral Vaccines Market, By Application, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Hematology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Infectious Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Cardiovascular Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends

7. Global Therapeutic Proteins and Oral Vaccines Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Therapeutic Proteins and Oral Vaccines Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Amgen, Inc.
    • Biogen, Inc.
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Johnson and Johnson
    • Merck & Co. Inc.
    • Novo Nordisk A/S
    • Pfizer, Inc.
    • Sanofi S.A.
    • Serum Institute of India Pvt. Ltd.
    • Emergent Biosolutions Inc.
    • TransAlgae
    • MigVax Ltd.
    • Lumen Bioscience, Inc.

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact